PrivilEdge - American Ctry Emerg Mar Equity USD MA

Ranked 158 out of 296 in - Global Emerging Markets over 12 months
All calculations are in GBP unless stated

Objective

The fund invests in in equity and equity-related securities of companies having their registered office, or listed, in an Emerging Market country. The Investment Manager may invest up to 35% of the Sub-Funds net assets in small-cap companies. Up to 20% of the Sub-Funds net assets may be invested in China A-Shares which are shares issued by mainland China-based companies that trade on regulated exchanges but only available for purchase through certain trading facilities (such as Stock Connect).

Showing fund performance in United Kingdom View performance globally

Performance

Global Emerging Markets over : 30/04/2018 - 30/04/2019

Total Return

Quarterly Performance

to 31/03/2019 Annual Q1 Q2 Q3 Q4
2019 7.6%
2018 -13.1% -3.6% -5.2% -1.1% -3.9%
2017 0.1% 2.5%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/03/2019

Top 10 Holdings

Stock Size
Tencent Holdings Ltd ORD 6.14%
Alibaba Group Holding Ltd DR 5.52%
Taiwan Semiconductor Manufacturing Co Ltd ORD 4.97%
Samsung Electronics Co Ltd ORD 3.58%
HDFC Bank Ltd DR 2.53%
Fila Korea Ltd ORD 2.52%
Naspers Ltd ORD 2.41%
CNOOC Ltd ORD 2.17%
Novatek PAO DR 2.07%
China Construction Bank Corp ORD 1.95%
31/03/2019

Registered For Sale In

  1. Belgium
  2. France
  3. Germany
  4. Italy
  5. Liechtenstein
  6. Luxembourg
  7. Netherlands
  8. United Kingdom

Fund Info

  • Launch date19/06/2017
  • Share Class size111Mn
  • Base currencyEUR
  • ISIN LU1605734653

Purchase Info

  • Min. initial investment3,000
  • Min. regular additional investment0

Charges

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).